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Background: The usage of medicinal plants is traditionally rooted in Bangladesh and still an essential part of public
healthcare. Recently, a dramatically increasing prevalence brought diabetes mellitus and its therapy to the focus of
public health interests in Bangladesh. We conducted an ethnobotanical survey to identify the traditional medicinal
plants being used to treat diabetes in Bangladesh and to critically assess their anti-diabetic potentials with focus on
evidence-based criteria.
Methods: In an ethnobotanical survey in defined rural and urban areas 63 randomly chosen individuals (health
professionals, diabetic patients), identified to use traditional medicinal plants to treat diabetes, were interviewed in a
structured manner about their administration or use of plants for treating diabetes.
Results: In total 37 medicinal plants belonging to 25 families were reported as being used for the treatment of
diabetes in Bangladesh. The most frequently mentioned plants were Coccinia indica, Azadirachta indica, Trigonella
foenum-graecum, Syzygium cumini, Terminalia chebula, Ficus racemosa, Momordica charantia, Swietenia mahagoni.
Conclusion: Traditional medicinal plants are commonly used in Bangladesh to treat diabetes. The available data
regarding the anti-diabetic activity of the detected plants is not sufficient to adequately evaluate or recommend
their use. Clinical intervention studies are required to provide evidence for a safe and effective use of the identified
plants in the treatment of diabetes.
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BangladeshIntroduction
Bangladesh features a sub-tropical climate and low-lying
landmass largely adjacent to extensive river deltas. The
country comprises very fertile soils and is home to some
rare ecosystems such as the Sundarbans mangrove for-
ests. Given the fertile plains and high population density,
the indigenous vegetation has mostly given way to
cropland and extensive cultivation. Today, almost 60%
of the landmass is used for farming, which is a global
maximum value. However, originally large parts of* Correspondence: hans.hauner@tum.de
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reproduction in any medium, provided the orBangladesh featured tropical forests and marshy jungle
with highly biodiverse flora - being also an excellent
source for medicinal plants.
The Bangladeshi traditional medicine is a unique con-
glomerate of different ethnomedical influences. Due to
the geographic location and sociocultural characteristics
of the country, it involves traditionally rooted elements
influenced by local indigenous people and close-by
Indian Ayurveda and Unani medicine [1,2]. Given its
inexpensive, easily accessible and well-established health
services, the use of traditional medicine is an integral
part of public health services in Bangladesh with its pro-
viders being deeply embedded within the local commu-
nity [3-5]. Recent data suggest that the utilization of
traditional medicine health services in Bangladesh is
widespread [6] and plays a crucial role in providingtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tribal people [4,7-13].
In the context of using traditional medicinal plants for
treating diabetes, extensive screening has been perfor-
med in many ethnomedical systems within the Indian
subcontinent [14,15]. However, in Bangladesh the trad-
itional medicinal plants that are used for the treatment of
diabetes have not yet been studied in great detail. There-
fore, these herbal remedies are important objects of re-
search, especially in context of the virtually exploding
prevalence of diabetes mellitus in Bangladesh. Although
diabetes is more prevalent in urban areas [16,17], in rural
communities prevalence rates for diabetes rose from
2.3% to 6.8% in between 1999 to 2004 [18].
A recent survey in Bangladesh demonstrated that in
slum areas, 86% of female and 78% of male diabetic pa-
tients use either inadequate medical treatment or none
[19]. In non-slum areas only 34% of female and male dia-
betic patients undergo adequate medical treatment [19]
raising the question, whether herbal remedies of the trad-
itional Bangladeshi medicine may offer a safe, effective
and reasonable alternative therapy for diabetes. To address
this question, an identification of the plants being used in
Bangladesh for the treatment of diabetes is essential. We
conducted an ethnobotanical survey in defined rural and
urban areas of Bangladesh to document and evaluate
which plants are used for the treatment of diabetes.
Material and methods
Study area
The study was performed in both an urban district of
Dhaka, as well as a rural region adjoining to the city.
The urban part was conducted in Dhaka, which is the
capital of Bangladesh and has an area of 304 km2.
According to the 2008 estimate of the Bangladesh Bur-
eau of Statistics, Dhaka has a metropolitan population of
about 12.8 m inhabitants, of which most are of Bengali
origin. Although the direct biodiversity in the city is
obviously quite low, Dhaka - with its offer of labor and
infrastructure - causes a continuous migration of new
residents from all over Bangladesh. This leads to a di-
verse background of the inhabitants and was a majorTable 1 Sample size and demographic data of key informants
Informant group No of persons (urban/rural)
Diabetic patients 9/9
Traditional healers (Kabiraj) 5/5
Indigenous medicine companies a 5/-
Private indigenous healing centers 5/5
Indigenous doctors b 5/5
Allopathic doctors 5/5
Average and range of age in years; average and range of professional experience o
companies; b = Indigenous doctors passed from Unani and Ayurvedic Medical Collereason for conducting the survey in several thanas (sub-
districts) in Dhaka on the professional informant side.
For the interviews with diabetic patients we focused pre-
dominantly on a previously recruited cohort residing in
the Mirpur subdistrict of Dhaka. The rural part of the
survey was conducted in Manikganj, which is a part of
Dhaka division. It is bounded by the Dhaka district on
the east and south and bordered by the Jamuna and
Padma River. The Manikganj district has an area of
1379 km2 and a population of 1.3 m inhabitants. Being a
former subdivision of the Dhaka district, it features a
rural environment with smaller towns and a lower popu-
lation density than the urban areas of Dhaka.
Ethnobotanical data collection and type of data collected
This study adhered to the research guidelines and ethical
protocols of the Technical University of Munich. The
aim of the study was to qualitatively identify traditional
medicinal plants known and accessible by the Bangladeshi
population. For this purpose, a dialogue with local polit-
ical and health service authorities was initiated for
authorization as well as support. To obtain the most
valuable information in a reasonable sample size, inter-
views of key informants were performed. Altogether 63
interviews were conducted, of which 29 were attributed
to rural and 34 to urban regions. To cover a diverse
spectrum of informants, different informant groups were
defined for participating in the study. From these in-
formant groups, key informants were randomly chosen
out of a pool of knowledgeable persons (Table 1). It is
noteworthy that the sample size of informants partici-
pating in this study was limited and not representative for
the study groups or regional distribution, so that quanti-
tative conclusions are not feasible. However, to screen
the data obtained in this study the overall frequency of
citation of plants was assessed and is indicated in the re-
sults (Table 2).
Interviews were conducted in the Bengali language
and based on a semi-structured question form with an-
swers recorded. Informed consent was obtained from
the participants for the publication of this report. The
questionnaire was designed to gather information onGender (female/male) Age Professional experience
6/12 53 (35–68) -
1/9 59 (25–82) 26 (2–50)
0/5 50 (25–66) 8 (3–14)
0/10 42 (25–57) 11 (1–23)
1/9 42 (30–65) 8 (1–25)
2/8 45 (39–52) 9 (4–20)
f health practitioners in years; a = Representatives from indigenous medicine
ge and hospitals.
Table 2 List of medicinal plants used in traditional medicine for the treatment of diabetes in Bangladesh
Botanical name
(Voucher specimen ID)
Family Local Name Plant parts used Stage of maturity Frequency
of citation
Achyranthes aspera L. (BD-01) Amaranthaceae Upat Lengra Root, whole plant M 0.85
Adiantum capillus-veneris L. (BD-02) Adiantaceae Hanglapudi, Gobalelota Seed M 0.85
Allium sativum L. (BD-03) Amaryllidaceae Rôsun Root, whole plant M 1.69
Andrographis paniculata Wall.
ex Nees (BD-04)
Acanthaceae Kālmegh Leaf, whole plant M 0.85
Asparagus racemosus L. (BD-05) Asparagaceae Sotomuli Root M, F 1.69
Azadirachta indica A. Juss. (BD-06) Meliaceae Neem Bark, leaf, seed M, F 8.47
Bunium persicum Bois. (BD-07) Apiaceae Kalo Jeera Seed, whole plant M 1.69
Centella asiatica L. (BD-08) Apiaceae Thankuni Leaf M 0.85
Coccinia indica W.&A. (BD-09) Cucurbitaceae Kundri, Telachuka Fruit, leaf, root, whole plant M, F, Pm 16.95
Cynodon dactylon (L.) Pers. (BD-10) Poaceae Durba Leaf, whole plant M, F 1.69
Datura stramonium L. (BD-11) Solanaceae Dhotura Seed M 0.85
Eclipta alba L. (BD-12) Asteraceae Bringoraj, Kalokeshi Leaf M 0.85
Ficus benghalensis L. (BD-13) Moraceae Bot, Kathali Pata Bot Leaf M, F 1.69
Ficus racemosa L. (BD-14) Moraceae Joiggidumur Bark, fruit M, Pm 4.24
Gymnema sylvestre R. Br. (BD-15) Asclepiadaceae Medhasingi, Gorshar Whole plant M 0.85
Heliotropium indicum L. (BD-16) Boraginaceae Hatisur Leaf M 0.85
Hemidesmus indicus L. R. Br. (BD-17) Apocynaceae Anantomul Root F 0.85
Lagerstroemia speciosa (L.) Pers. (BD-18) Lythraceae Jarul Leaf M 2.54
Mangifera indica L. (BD-19) Anacardiaceae Aam Seed M 0.85
Mimosa pudica L. (BD-20) Fabaceae Lojjaboti, Sada Lojjaboti Whole plant M 0.85
Momordica charantia L. (BD-21) Cucurbitaceae Kôrola Fruit, leaf, whole plant M, F 4.24
Musa sapientum L. (BD-22) Musaceae Kôla Fruit M 0.85
Ocimum sanctum L. (BD-23) Lamiaceae Krisno Tulshi, Kalo Tulshi Whole plant M, F 0.85
Phyllanthus emblica L. (BD-24) Phyllanthaceae Amloki Fruit, seed, whole plant M, F 3.39
Swertia chirata L. (BD-25) Gentianaceae Chirota Root - 0.85
Swietenia mahagoni Jacq. (BD-26) Meliaceae Mahogany Seed M, F 4.24
Syzygium cumini (L.) Skeels (BD-27) Myrtaceae Jam Leaf, seed M, F 7.63
Tamarindus indica L. (BD-28) Fabaceae Tetul Seed M 1.69
Terminalia arjuna W.&A. (BD-29) Combretaceae Arjun Seed M 0.85
Terminalia bellirica L. (BD-30) Combretaceae Bohera, Jonglee Bohera Seed M, F 3.39
Terminalia chebula Retz. (BD-31) Combretaceae Horituki Seed M, F 5.08
Tinospora cordifolia Hook.
F. & Thoms. (BD-32)
Menispermaceae Gulancha lota Bark, leaf, root, whole plant M 3.39
Trigonella foenum-graecum L. (BD-33) Fabaceae Methi Seed, whole plant M, F 8.47
Vernonia anthelmintica Willd. (BD-34) Asteraceae Somraj Whole plant M 0.85
Vinca rosea L. (BD-35) Apocynaceae Golapi Noyontara Leaf F 0.85
Vitex negundo L. (BD-36) Lamiaceae Nirgundi, Nishinda, Samalu Leaf M 0.85
Withania somnifera (L.) Dunal (BD-37) Solanaceae Aswagandha Leaf, root, whole plant M, F 2.54
Alphabetically listed with plant parts used (listed alphabetically); stage of maturity of plant when being used (M =mature, F = fresh, Pm = premature); frequency of
citation by informants.
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knowledge about diabetes (and its diagnosis), access to
allopathic medicine, and medicinal plants used in the
therapy of diabetes. Formulations of plants were notincluded in this survey. Every key informant was
interviewed once. Medicinal plants being mentioned by
the informant were recorded with local names and
photographed. Whenever possible, informants were
Figure 1 Parts used for the treatment of diabetes from all plants (A) and the most frequently mentioned plants (B). Multiple answers
possible, some informants did not mention any specific plant parts.
Figure 2 Regional distribution of the most frequently
mentioned plants.
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treatment of diabetes. The documented plants and sam-
ples were dried, stored and identified with the help of a
botanist.
Data analysis
The frequency of citation was calculated to assess the in-
cidence of one particular plant species used for the treat-
ment of diabetes in relation to the overall citations for
all plants. The frequency of citation for a plant species
was calculated as follows: Frequency of citation for a
particular species = (Number of citations for that par-
ticular species/Number of all citations for all species)
*100. For the most mentioned medicinal plants of the
survey, a literature search was performed with special
focus on diabetes-related clinical data.
Results
The 63 conducted key informant interviews of the ethno-
botanical survey revealed 37 different plants that were
mentioned by informants for anti-diabetic treatment indi-
vidually or combined with other plants (Table 2). Regard-
ing the overall frequency of citation, the most cited plants
were Coccinia indica, Azadirachta indica, Syzygium
cumini, Trigonella foenum-graecum, Terminalia chebula,
Ficus racemosa, Momordica charantia and Swietenia
mahagoni, suggesting a prominent role of these plants in
the herbal treatment of diabetes.
Leaves and seeds at a defined stage of maturity were
most frequently cited to be used for treatment or prep-
aration of the traditional medicine (Figure 1A). Interest-
ingly, plant parts used from the most frequently
mentioned plants were consistent with the exception of
Momordica charantia (Figure 1B).
To receive an impression of regional availability of the
top-mentioned plants, the number of citations in urban
and rural areas was compared. Though only a few moreinformants were interviewed in urban areas (Table 1),
the number of citations by urban informants prevails
considerably for most plants (Figure 2). Trigonella
foenum-graecum and Momordica charantia were exclu-
sively mentioned by urban informants.
Finally, the most frequently mentioned plants were
analyzed regarding times mentioned by the relevant in-
formant groups for herbal treatment of diabetes. Admit-
tedly quantitative comparisons between the groups were
not feasible due to overall low numbers of informants
and the high number of diabetic patients outnumbering
all other groups. However, all top-mentioned plants
were known by a minimum of three informant groups,
suggesting a broad propagation of these plants within
the different diabetes-related groups (Figure 3). The
most mentioned medicinal plant, Coccinia indica, was
also most prevalently used in the diabetic patients group
highlighting its prominent role in herbal treatment of
diabetes in the study area. In contrast, Coccinia indica
Figure 3 Citation of most frequently mentioned plants related to informant groups.
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group. Interestingly, most of the not top-mentioned plants
were cited by the Kabiraj informant group (Figure 3).Discussion
Overall, the survey revealed 37 medicinal plants belong-
ing to 25 families that are used to treat diabetes in
Bangladesh. Due to limited sample size, we focused this
discussion on the most frequently mentioned plants.
Regarding all identified plants, leaves and seeds were
the major plant parts used, which is in agreement with
other studies [12,20,21]. The collection and processing
of leaves and seeds is easy [21], and does not damage
the plant substantially as compared to the collection of
roots or the whole plant [22,23]. Leaves and seeds may
contain or accumulate the pharmacologically active
agents of plants. For example, these were reported for
the seeds of Trigonella foenum-graecum [24,25] and
Syzygium cumini [26] and the leaves of Coccinia indica
[27-29] and Azadirachta indica [30].
A recent survey recorded plant parts similar to our
study for Coccinia indica, Azadirachta indica, Syzygium
cumini, Trigonella foenum-graecum, Terminalia chebula
and Momordica charantia used in the treatment of dia-
betes by traditional health practitioners in Bangladesh
[12]. In contrast to our study, Kadir et al. mentioned
bark and root of Ficus racemosa to be used as medicinal
plant component. Although most studies show anti-
diabetic properties for the bark of Ficus racemosa
[31,32], anti-diabetic agents were also isolated from its
fruits [33]. Interestingly, Swietenia mahagoni was not
reported as a medicinal plant used for the treatment of
diabetes in Bangladesh. Since Swietenia mahagoni is not
indigenous to Bangladesh, it may not be a common trad-
itional medicinal plant for this area. However, it was
cited by indigenous doctors (Ayurveda/Unani) as well as
traditional Kabiraj healers in this survey. Recent reportsemphasize the hypoglycemic and anti-oxidant activity of
Swietenia mahagoni bark and seed extracts [34,35].
Regarding the regional distribution of plants, the most
top-mentioned plants seem to be similarly available in
urban and rural regions. Higher availability of plants in
urban regions may reflect the role of Dhaka as
socio-economic and commercial center of the country.
Trigonella foenum-graecum and Momordica charantia
were only mentioned by urban informants, suggesting a
general low local availability of these plants in the rural
surroundings of Dhaka. However, Trigonella foenum-
graecum [24] and Momordica charantia [36,37] are
widely available at local markets in Bangladesh.
Coccinia indica was mentioned by one third of all in-
formants for being used as an anti-diabetic agent. In
Bangladesh, Coccinia indica is well-known as an ayur-
vedic medicinal plant and is used for the treatment of
diabetes [12,27,28]. It seems to be largely available in the
area of Dhaka, since it was mentioned by most infor-
mants from the diabetic patients group. Leaves of
Coccinia indica showed hypoglycemic effects in several
animal studies [29,36,38,39] and small human interven-
tion trials [28,40,41]. Though showing promising prelim-
inary results, the anti-diabetic efficacy of Coccinia indica
is not convincing due to the lack of solid evidence from
extensive clinical intervention studies.
Momordica charantia is an edible vegetable commonly
known as bitter gourd. It is widely available in
Bangladesh and also well-known as an agent with several
anti-diabetic effects [36,37,42,43]. Numerous studies re-
vealed anti-hyperglycemic effects for its fruits in experi-
mental animal studies of induced diabetes [36,37,44-46],
but also the leaves, stem and seeds were reported to be
used for anti-diabetic treatment [12]. Conflicting results
were reported by small clinical trials; only modest
hypoglycemic effects less distinct than for metformin
were shown in type 2 diabetes mellitus patients [47], and
no effect on the levels of plasma insulin and glucose was
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outcomes for Momordica charantia regarding clinical
trials [49].
Several small preliminary clinical studies investigating
the effect of seed extracts of Trigonella foenum-graecum
revealed a significantly reduced insulin resistance [50]
and improved fasting and postprandial blood glucose
levels [51,52] in diabetic patients. Isolated compounds of
fenugreek, when administered in addition to sulfonyl-
ureas, also showed an improved anti-diabetic action
compared to sulfonylureas alone in diabetic patients
[53]. Since there are relatively many, but rather small
human clinical trials available for fenugreek, it is one of
the most interesting candidate plants for effective and
safe anti-diabetic therapy.
Azadirachta indica is a common medicinal plant for
tribal people in Bangladesh [12,13]. Anti-hyperglycemic
effects in normal or diabetes-induced animal models
were shown for leaf extracts of Azadirachta indica
[30,39,54,55]. Seed extracts had significant hypoglycemic
activity in a small cohort of type 2 diabetes patients [56].
For Ficus racemosa, few animal studies report blood
glucose lowering activity [31-33,57]. In a preliminary
clinical trial, treatment of type 2 diabetic patients with
bark extracts of Ficus racemosa resulted in significantly
reduced blood glucose levels and increased serum insu-
lin levels [58].
Anti-diabetic effects were shown for Terminalia
chebula [59-63] and Syzygium cumini [26,64,65] in nor-
mal or diabetes-induced animal models, but not in
healthy individuals [66].
Conclusion
The available clinical data suggesting anti-diabetic activ-
ity of plants identified in this survey is limited. Most of
the clinical studies lacked sufficient sample size, ran-
domized controlled study design or revealed only low
anti-diabetic efficacy following the treatment with plants.
In this context, it is also questionable to what extent the
numerous anti-diabetic effects of plants and their ex-
tracts found in experimental animal and in vitro studies
can be extrapolated to human settings. Out of the identi-
fied 37 plants used for the treatment of diabetes in
Bangladesh only a few were shown to eventually exert
anti-diabetic activity in clinical studies.
We henceforth propose to focus future research on
the conduction of high-quality clinical studies while con-
centrating on those plants which show the most promis-
ing anti-diabetic efficacy in already performed clinical
studies. In this context, it is also of particular interest to
include safety issues and to study dose-dependent rela-
tionships. There are several other plants identified in this
study of potential interest as preliminary data from ani-
mal or in vitro studies may indicate some anti-diabeticactivity. But this has to be further investigated by clinical
trials meeting the requirements of evidence-based medi-
cine [67]. Such studies are of enormous public health
interest as they may offer an evidence-based and safe
use of non-expensive plant-derived medications against
the growing epidemic of diabetes, particularly for low-
income countries such as Bangladesh.
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